These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37142947)

  • 1. Prognosis and incidence of infections in chronic kidney disease patients with membranous nephropathy enrolled in a large Japanese clinical claims database.
    Matsuzaki T; Watanabe Y; Tanaka A; Furuhashi K; Saito S; Maruyama S
    BMC Nephrol; 2023 May; 24(1):126. PubMed ID: 37142947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
    von Groote TC; Williams G; Au EH; Chen Y; Mathew AT; Hodson EM; Tunnicliffe DJ
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD004293. PubMed ID: 34778952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome.
    Saito T; Iwano M; Matsumoto K; Mitarai T; Yokoyama H; Yorioka N; Nishi S; Yoshimura A; Sato H; Ogahara S; Sasatomi Y; Kataoka Y; Ueda S; Koyama A; Maruyama S; Nangaku M; Imai E; Matsuo S; Tomino Y;
    Clin Exp Nephrol; 2017 Dec; 21(6):961-970. PubMed ID: 27783276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early initiation of immunosuppressive treatment in membranous nephropathy patients.
    Chan CK; Lai TS; Chen PM; Chou YH; Wu CF; Chiu YL; Chiang WC; Chen YM; Chu TS; Wu KD
    J Formos Med Assoc; 2017 Apr; 116(4):266-275. PubMed ID: 28202222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis of Japanese membranous nephropathy patients with nephrotic syndrome.
    Nishi S; Ueno M; Shimada H; Karasawa R; Nakamaru T; Miyakawa Y; Arakawa M
    Kidney Int Suppl; 1997 Dec; 63():S177-8. PubMed ID: 9407452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary N-acetyl-β-glucosaminidase and estimated Glomerular filtration rate may identify patients to be treated with immuno-suppression at diagnosis in idiopathic membranous nephropathy.
    Bazzi C; Usui T; Rizza V; Casellato D; Gallieni M; Nangaku M
    Nephrology (Carlton); 2018 Feb; 23(2):175-182. PubMed ID: 27764902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
    Chen Y; Schieppati A; Chen X; Cai G; Zamora J; Giuliano GA; Braun N; Perna A
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004293. PubMed ID: 25318831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive agents for treating IgA nephropathy.
    Natale P; Palmer SC; Ruospo M; Saglimbene VM; Craig JC; Vecchio M; Samuels JA; Molony DA; Schena FP; Strippoli GF
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD003965. PubMed ID: 32162319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous pulse cyclophosphamide and steroids induce immunological and clinical remission in New-incident and relapsing primary membranous nephropathy.
    Kanigicherla DAK; Hamilton P; Czapla K; Brenchley PE
    Nephrology (Carlton); 2018 Jan; 23(1):60-68. PubMed ID: 27778424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes in idiopathic membranous nephropathy using a restrictive treatment strategy.
    van den Brand JA; van Dijk PR; Hofstra JM; Wetzels JF
    J Am Soc Nephrol; 2014 Jan; 25(1):150-8. PubMed ID: 24029426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An 8-month-old boy with infantile nephrotic syndrome caused by semaphorin 3B-associated membranous nephropathy.
    Tanaka Y; Yamamoto M; Nozu K; Hara S
    CEN Case Rep; 2023 Aug; 12(3):281-286. PubMed ID: 36504250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features, course and prognosis of idiopathic membranous nephropathy depending on the presence of antibodies against M-type phospholipase A2 receptor.
    Jatem Escalante E; Segarra Medrano A; Carnicer Cáceres C; Martín-Gómez MA; Salcedo Allende MT; Ostos Roldan H; Agraz Pamplona I
    Nefrologia; 2015; 35(5):479-86. PubMed ID: 26306972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient age and the prognosis of idiopathic membranous nephropathy.
    Yamaguchi M; Ando M; Yamamoto R; Akiyama S; Kato S; Katsuno T; Kosugi T; Sato W; Tsuboi N; Yasuda Y; Mizuno M; Ito Y; Matsuo S; Maruyama S
    PLoS One; 2014; 9(10):e110376. PubMed ID: 25330372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting outcome and prognosis in membranous lupus nephropathy.
    Mercadal L; Montcel ST; Nochy D; Queffeulou G; Piette JC; Isnard-Bagnis C; Martinez F
    Nephrol Dial Transplant; 2002 Oct; 17(10):1771-8. PubMed ID: 12270983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial.
    Howman A; Chapman TL; Langdon MM; Ferguson C; Adu D; Feehally J; Gaskin GJ; Jayne DR; O'Donoghue D; Boulton-Jones M; Mathieson PW
    Lancet; 2013 Mar; 381(9868):744-51. PubMed ID: 23312808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple therapy with single daily dose of cyclosporine in Japanese patients with idiopathic membranous nephropathy.
    Matsumoto H; Nagaoka Y; Okada T; Wada T; Gondo A; Esaki S; Hayashi A; Miyaoka Y; Nakao T
    Intern Med; 2011; 50(18):1905-10. PubMed ID: 21921367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Membranous nephropathy: New insights in therapeutic approach].
    Dahan K
    Nephrol Ther; 2017 Apr; 13 Suppl 1():S83-S87. PubMed ID: 28577748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting risk of pulmonary infection in patients with primary membranous nephropathy on immunosuppressive therapy: The AIM-7C score.
    Wang T; Zhang Y; Ping F; Zhao H; Yan L; Lin Q; Zhang H
    Nephrology (Carlton); 2019 Oct; 24(10):1009-1016. PubMed ID: 30499223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid treatment in patients with membranous nephropathy and hepatitis B virus surface antigenemia: a report of two cases.
    Akimoto T; Otake T; Tanaka A; Takahashi H; Higashizawa T; Inoue M; Nishino K; Saito O; Isoda N; Muto S; Sugano K; Kusano E
    Clin Exp Nephrol; 2011 Apr; 15(2):289-93. PubMed ID: 21170566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal outcomes of idiopathic and atypical membranous nephropathy in adult Chinese patients: a single center retrospective cohort study.
    Jiang Z; Cai M; Dong B; Yan Y; Wang Y; Li X; Shao C; Zuo L
    BMC Nephrol; 2021 Apr; 22(1):148. PubMed ID: 33888083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.